Home Healthcare Medical Devices Chest Drainage System Market

Chest Drainage System Market Size, Share & Trends Analysis Report By Product Type (Chest Drainage System, Pleural Drainage Catheters, Thoracic Drainage Kits, Trocar Drains, Accessories), By Application (Thoracic Surgery & Pulmonology, Cardiac Surgery, Trauma & Emergency Medicine, Oncology & Pain Management), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Home Healthcare) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 23, 2026 | Author: Debashree Bora | Format:

Chest Drainage System Market Size & Share Analysis

The global chest drainage system  market size was valued at USD 922.51 million in 2025 and is projected to grow from USD 974.54 million in 2026 to USD 1511.56 million by 2034, registering a CAGR of 5.64% during the forecast period (2026-2034). North America dominated the chest drainage system market with a share of 38.59% in 2025.

Chest drainage systems are medical devices designed to remove air, blood, pus, and other fluids from the pleural cavity to restore normal lung expansion and support respiratory function. They are tracked under HSN Code 9018 (instruments and appliances used in medical, surgical, or diagnostic sciences) and SIC Code 3841 (surgical and medical instruments and apparatus).

The chest drainage system market demand is driven by the high prevalence of respiratory conditions and the need for effective management of pleural disorders. Healthcare providers are adopting advanced chest drainage systems with improved fluid collection, air leak monitoring, and drainage control features, contributing to chest drainage system market growth.

Chest Drainage System Market Key Takeaways

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.59%
Fastest-growing Region
Asia Pacific
Asia Pacific CAGR (2026-2034)
7.13%

Segment Insights

By Product
Leading Segment
Chest Drainage System
Market Share in 2025 43.5%
By Application
Fastest-growing Segment
Oncology & Pain Management
CAGR 6.82% (2026-2034)
By End User
Leading Segment
Hospitals
Market Share in 2025 66.5%
Chest Drainage System Market Size

Download a Free Sample To learn more about this report.

Chest Drainage System Market Dynamics

01

Use of Digital Air-Leak Monitoring and Anti-Clogging Drainage Designs Drives Market

Use of digital chest drainage systems for objective air-leak measurement strengthens demand for advanced drainage equipment in thoracic surgery units. These systems provide continuous measurements of air leakage and fluid output, helping clinicians assess lung re-expansion and determine the appropriate timing for chest tube removal. 

Blood clot formation within drainage tubes obstructs the removal of blood from the pleural cavity in patients with traumatic hemothorax. This creates demand for chest drainage systems with effective fluid pathways and designs that help maintain drainage patency during treatment. Improved drainage performance encourages the use of specialized drainage equipment in trauma centers and emergency care units.

01

Risk of Drainage Tube Blockage and High Digital Drainage System Costs Restrain Market Expansion

Blood clots, thick fluid, and tissue debris  obstruct chest drainage tubes and interfere with the removal of air or fluid from the pleural cavity. Such blockages require tube flushing, repositioning, or replacement, increasing the complexity of patient monitoring and drainage management.

Digital chest drainage systems generally involve higher initial equipment costs than conventional water-seal drainage systems, along with expenses for compatible disposable components and ongoing maintenance. These costs create purchasing constraints for hospitals with limited capital budgets, particularly when replacing conventional equipment across multiple wards and surgical units.

01

Expansion of Ambulatory Chest Drainage Solutions and Development of Clot-Resistant Drainage Chambers Offers Growth Opportunities

Need for continued chest drainage among selected patients with prolonged air leaks is creating opportunities for manufacturers to develop portable systems suitable for ambulatory care. These solutions  support patient mobility and allow eligible individuals to continue recovery outside acute-care settings under appropriate clinical supervision.

Enhanced drainage pathways and designs that reduce blockage help maintain effective fluid removal and limit interruptions in drainage. Manufacturers can open new revenue avenues by providing products focused on improved clot management, dependable drainage performance, and features that support emergency and trauma care teams.

Chest Drainage System Market Segmentation Analysis

By Product

Chest drainage systems accounted for a dominant share of 43.5% in 2025, owing to their essential role in removing air, fluid, and blood from the pleural cavity and supporting lung re-expansion. 

Automated systems segment is projected to undergo growth at a CAGR of 9.45% during the forecast period, driven by increasing demand for precise drainage monitoring, reduced manual intervention, and improved patient management.

Chest Drainage System Market Size By Segments

Request Customizationto receive a tailored report.

By Application

In 2025, the thoracic surgery and pulmonology segment dominated the application category with a share of 42.5%, owing to the extensive use of chest drainage systems in thoracic procedures and the management of pleural conditions.

The oncology and pain management segment is projected to undergo growth at a CAGR of 6.82% during the forecast period, driven by the need for chest drainage in managing pleural effusions associated with cancer and related complications.

By End User

Hospitals led the end user segment with a share of 66.5% in 2025, supported by the availability of advanced surgical facilities, specialized medical professionals, and comprehensive patient care services. Hospitals continue to use chest drainage systems to manage pneumothorax, pleural effusion, and post-surgical complications, supporting demand across surgical departments and critical care units.

Home healthcare is likely to grow at a CAGR of 8.25% during the forecast period, fueled by the shift toward home-based recovery and the need for effective management of chest drainage after hospital discharge. 

Chest Drainage System Market Share By Segments

Speak to an Analystto discuss market opportunities.

Clinical Risk Grouping Solution Market Regional Analysis

North America Clinical Risk Grouping Solution Market

North America's clinical risk grouping solution market accounted for a dominant share of 38.59% in 2025.

U.S. Clinical Risk Grouping Solution Market

The Centers for Medicare & Medicaid Services (CMS) uses risk adjustment methodologies to account for differences in patient health status and expected healthcare costs across populations. These requirements encourage healthcare providers and technology developers to adopt clinical risk grouping solutions that support patient stratification, population health management, and value-based care reimbursement.

Canada Clinical Risk Grouping Solution Market

Canadian Institute for Health Information (CIHI) continue advancing clinical data standardization through the Canadian Core Data for Interoperability (CACDI). It establishes standardized health data elements and value sets to improve information exchange across healthcare systems, supporting the integration of patient records in healthcare resource planning.

North America Chest Drainage System Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Clinical Risk Grouping Solution Market

The Asia Pacific clinical risk grouping solution market will expand at a CAGR of 7.13%, showcasing the fastest-growing regional market.

Japan Clinical Risk Grouping Solution Market

Japan’s healthcare sector is increasingly focused on digital health technologies, population health management, and data-driven healthcare planning. These initiatives support the adoption of clinical risk grouping solutions to improve patient risk stratification, chronic disease management, and healthcare resource allocation across the country.

China Clinical Risk Grouping Solution Market

The Chinese market is supported by expanding healthcare digitalization, the demand for population health management, and the adoption of data-driven clinical decision-making. Investments in healthcare information technology and the development of digital health infrastructure continue to strengthen the country's clinical risk grouping solution market.

India Clinical Risk Grouping Solution Market

Ayushman Bharat Digital Mission promotes the development of integrated digital health infrastructure to improve healthcare data exchange and patient information management. These initiatives support the adoption of clinical risk grouping solutions for patient risk stratification, chronic disease management, and data-driven healthcare planning across India.

Europe Clinical Risk Grouping Solution Market

Europe's clinical risk grouping solution market is anticipated to grow at a CAGR of 5.12% during the forecast period.

U.K. Clinical Risk Grouping Solution Market

NHS England uses risk stratification tools to analyze clinical and demographic data and identify patients at higher risk of diabetes, heart disease, and unplanned hospital admissions. These tools support demand for clinical risk grouping solutions across the UK by helping Integrated Care Boards identify high-risk patient groups, prioritize preventive interventions, and improve healthcare resource allocation.

Germany Clinical Risk Grouping Solution Market

According to Germany’s Federal Ministry of Health, inpatient hospital services are classified using specialized software that considers diagnoses, disease severity, surgical procedures, and other treatment-related factors to determine the applicable reimbursement category. Germany’s Hospital Care Improvement Act introduced reforms to strengthen quality-oriented hospital planning and complement activity-based reimbursement with capacity-based funding.

Latin America Clinical Risk Grouping Solution Market

The Latin American clinical risk grouping solution market is anticipated to grow at a CAGR of 6.15% during the forecast period. Brazil's Ministry of Health launched the SUS Sovereign Cloud initiative to strengthen domestic control and security of healthcare data. Mexico's Ministry of Health and the Mexican Social Security Institute implemented interoperable electronic health records across public healthcare institutions.

Middle East & Africa Clinical Risk Grouping Solution Market

The Middle East & Africa clinical risk grouping solution market is projected to grow at a CAGR of 6.48% during the forecast period. In the UAE, the national genomic program strengthens the need for clinical risk stratification and predictive analytics solutions. South Africa's Digital Health Interoperability Projectathon tested secure data exchange, creating a stronger foundation for clinical risk grouping and population health analysis.

Competitive Landscape

The chest drainage system market competitive landscape includes established medical device manufacturers, respiratory care specialists, and hospital equipment providers. Key players such as Teleflex, Getinge, Medela, and B. Braun Melsungen are estimated to account for 30–40% of the global chest drainage system market share.

Established players compete through drainage efficiency, patient safety, and system reliability. Emerging players in the chest drainage system market focus on portable drainage units, digital air leak monitoring, and compact systems for postoperative recovery.

List of Key and Emerging Players in Chest Drainage System Market

Teleflex Incorporated (US)
BD (US)
Getinge AB (Sweden)
Medela AG (Switzerland)
B. Braun Melsungen AG (Germany)
Sinapi Biomedical (South Africa)
Cook Medical (US)
Merit Medical Systems (US)
Cardinal Health (US)
Vygon (France)
Redax (Italy)
Rocket Medical (UK)
Utah Medical Products (US)
Eurosets (Italy)

Key Industry Developments

February 2026: Medela received a contract from Vizient for its Thopaz+ Digital Chest Drainage System.

February 2026: ClearFlow received an Innovative Technology contract from Vizient for its PleuraFlow Active Clearance Technology (ACT) system. 

Report Scope

Segmentation

By Product Type 5
  • Chest Drainage System
  • Pleural Drainage Catheters
  • Thoracic Drainage Kits
  • Trocar Drains
  • Accessories
By Application 4
  • Thoracic Surgery & Pulmonology
  • Cardiac Surgery
  • Trauma & Emergency Medicine
  • Oncology & Pain Management
By End User 4
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • Home Healthcare

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Teleflex Incorporated (US) · BD (US) · Getinge AB (Sweden) · Medela AG (Switzerland) · B. Braun Melsungen AG (Germany)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The chest drainage system market size is valued at USD 974.54 million in 2026 and is projected to reach USD 1,511.56 million by 2034, at a CAGR of 5.64% during the forecast period 2026-2034.

North America dominated the chest drainage system market with a share of 38.59% in 2025.

The leading brands in this market are Teleflex Incorporated, BD, Getinge AB, Medela AG, and B. Braun Melsungen AG.

The chest drainage system market is projected to grow at a CAGR of 5.64% during the forecast period of 2026-2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: